Agile 4
Identification of cirrhosis in patients with MASLD.
Learn more
Agile 3+
Identification of advanced fibrosis in MASLD patients.
Agile 3+ utilizes FibroScan®-based Biomarkers.
Agile 3+ Target
Although MASLD is the most common chronic liver disease worldwide, early intervention can reverse liver damage and improve patient outcomes.
Identifying patients with advanced fibrosis (F≥3 according to NASH CRN scoring system) is key for the management of patients with MASFD since they are at increased risk of developing liver-related complications.
Agile 3+ Construction
Agile 3+ combines LSM by VCTE™ with easily accessible blood biomarkers (AST, ALT, Platelets) to help in the identification of advanced fibrosis in MASLD patients with optimized Positive Predictive values compared to LSM alone and help in the prediction of liver complications.
Formula
Agile 3+ Performance
High clinical performances demonstrated in large external validation cohorts from different geographical origins.
Peer reviewed paper under submission
Sanyal et al., Enhanced diagnosis of advanced fibrosis and cirrhosis in non-alcoholic fatty liver disease patients with FibroScan®-based Agile scores
Agile 3+: tried and trusted
A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of advanced fibrosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population. In addition, external validation on primary and secondary care centers could assess its potential as a new tool to refer patients to liver specialists.
Agile 3+ and Agile 4 well predict the occurrence of liverrelated events in patients with MASLD. Particularly, rule-in cut-offs of both scores better identify at-risk patients than LSM alone. These results demonstrate the interest of those scores in the identification of patients requiring hepatocellular carcinoma and esophageal varices screening.
All our solutions come with a dedicated support
From installation, to training and local support, we provide you with the highest quality of services.
Agile 3+ Score Calculator is a registered class 1 device (FDA). Agile 3+ Score Calculator is intended to compute the Fast score.
Agile 3+ Score Calculator was developed based on pools of cohorts and are published in peer-reviewed literature. It is taken from clinical literature and utilize proprietary FibroScan measurements in their execution. While these scores are about specific medical and health issues, Echosens does not represent them as substitutes for, or replacements of personalized medical advice, or to be used as the sole basis for making individualized medical or health-related decisions.
*MASLD/MASH is formerly knowed as NAFLD/NASH
